Treo Ventures

About The Fund

Treo Ventures, strategically positioned in Santa Clara, California, with a secondary office in Ireland, operates as a venture capital firm dedicated to the advancement of the healthcare industry. They possess a clear investment thesis centered on supporting medical technology companies embedded within the US, Ireland, and the broader European market. The firm proactively seeks opportunities within the medical device and digital health spheres focused on innovative solutions capable of making significant impacts on human health. With a deep commitment to fostering medical breakthroughs, Treo Ventures targets companies that are not only based in crucial healthcare-innovation hubs like Silicon Valley but also those that extend their reach across the Atlantic. They leverage their global presence to tap into a wealth of pioneering developments in medical sciences. Treo Ventures takes pride in a diverse yet strategic portfolio, showcasing investments in avant-garde neuromodulation therapies for large patient populations, revolutionary medical device companies reshaping treatment landscapes for venous occlusions, novel therapies for Restless Legs Syndrome, and implantable medical device technology aimed at chronic illnesses with minimally invasive solutions. Further evidence of their dedication is reflected in their support for accelerators and spin-off initiatives, such as NuXcel and ShiraTronics, which indicate a far-reaching vision that spans from ingenious startups to matured, market-shaping endeavors. Their active backing of ventures like Neuspera Medical, Inc. and the FDA-recognized CVRx, cements their role in driving forward the envelope of bioelectronic medicine and cardiovascular health. Additionally, their investment in entities like Hyalex, with its groundbreaking orthopedic polymer technology, illustrates a keen eye for transformative healthcare advancements.